Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.25
Delayed Data
As of May 25
 +0.25 / +5.00%
Today’s Change
3.92
Today|||52-Week Range
8.38
+12.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$684.1M

Company Description

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.

Contact Information

Keryx Biopharmaceuticals, Inc.
12th Floor
Boston Massachusetts 02210
P:(617) 466-3500
Investor Relations:
(617) 466-3511

Employees

Shareholders

Other institutional71.31%
Mutual fund holders22.18%
Individual stakeholders13.48%

Top Executives

Jodie P. MorrisonChief Executive Officer & Director
Christine A. CarberryChief Operating Officer & Senior Vice President
Scott A. HolmesChief Financial Officer & Senior Vice President
John F. NeylanChief Medical Officer & Senior Vice President
Melissa Bradford-KlugChief Business Officer & Senior Vice President